ArticleFrontiers in surgery2025
Perinatal factors for antepartum hemorrhage in women with placenta accreta spectrum.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Placenta accreta spectrum with antepartum hemorrhage is closely related to maternal and fetal morbidity and mortality. It is of utmost importance to predict the possibility of antepartum hemorrhage using perinatal factors before delivery in women with placenta accreta spectrum. The aim of this study is to identify the risk factors for antepartum hemorrhage in women with placenta accreta spectrum. Methods: This retrospective cohort study evaluated pregnant women with placenta accreta spectrum. Multivariate logistic regression was used to identify the independent variables associated with antepartum hemorrhage and a nomogram was developed to predict the possibility of antepartum hemorrhage. An Excel form computer interface was constructed to use the prediction model. Results: This retrospective cohort study included 188 participants (74 with antepartum hemorrhage). According to multivariate logistic regression analysis, blood type O [odds ratio (OR) 2.277, confidence interval (CI) 1.220-4.250], history of miscarriage (2.178, 95% CI 1.114-4.261), and parity (1.701, 1.037-2.790) were independent risk factors for antepartum hemorrhage in women with placenta accreta spectrum. Discussion: This results revealed that women with placenta accreta spectrum with blood type O, history of miscarriage, and multiparity may have a significant risk of experiencing antepartum hemorrhage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.